Azenta, Inc. (0HQ1.L)
- Previous Close
29.31 - Open
25.40 - Bid --
- Ask --
- Day's Range
25.12 - 25.40 - 52 Week Range
25.12 - 69.06 - Volume
34 - Avg. Volume
79 - Market Cap (intraday)
2.25B - Beta (5Y Monthly) 1.66
- PE Ratio (TTM)
0.01 - EPS (TTM)
29.66 - Earnings Date May 6, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
www.azenta.com3,000
Full Time Employees
September 30
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 0HQ1.L
View MorePerformance Overview: 0HQ1.L
Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0HQ1.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0HQ1.L
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-24.44%
Return on Assets (ttm)
-1.65%
Return on Equity (ttm)
-7.99%
Revenue (ttm)
662.11M
Net Income Avi to Common (ttm)
-166.4M
Diluted EPS (ttm)
29.66
Balance Sheet and Cash Flow
Total Cash (mrq)
463.44M
Total Debt/Equity (mrq)
3.16%
Levered Free Cash Flow (ttm)
11.1M